KDDF, 국가신약개발재단, 국가신약개발사업, 코로나19치료제·백신신약개발사업, 범부처전주기신약개발사업, 임상시험

2021年3月4日 · The Ministry of Science and ICT announced the plan on Thursday along with the appointment of Mook Hyun-sang as the new head of Korea Drug Development Fund (KDDF). The fund will explore effective and lead compounds and support drug development processes that span non-clinical and early-phase clinical trials. .. Read more.

Established in September 2011, Korea Drug Development Fund (KDDF) is a government-initiated drug development program. It aims to transform Korea into the global leader for new drug development....

Korea Drug Development Fund (KDDF) is helping turn cutting-edge science into breakthrough cancer treatments. With a budget of $1 billion, KDDF has funded 162 drug development projects, helping...

KDDF Global C&D Tech Fair는 글로벌 신약 개발을 위한 기술 교류 및 협력의 장입니다.

The Korea Drug Development Fund (KDDF) is the largest public funder of drug research and development (R&D) in Korea. View all 11 employees

KDDF is a national consortium of three government ministries and was established in 2011 to foster drug development program in Korea. With a mission to advance Korea’s biomedicine technologies and meet global standards, KDDF aims to actively fund and provide the necessary support for drug development.

形成独具上药康德乐（上海） 特色的复合型双体系医药服务管理模式，为生物医药产业的高质量发展注入强劲动力，并助力“健康中国”目标的实现，打造行业新标杆。 上药康德乐（上海）医药有限公司专注于药品，器械，医美等大健康领域的专业赛道，提供数智化一体化的供应链创新服务和电商服务。 我们优化业务流程，建立全面的质量管理体系，确保供应链服务的全过程质量。 通过这种复合型管理模式，我们为生物医药产业的发展贡献力量，并助力实现“健康中国”目标，树立 …

ILIAS Biologics, Inc. announced that its project to develop exosome-based IBD treatment has been selected as the winner of the 2022 KDDF National New Drug Development Project an..

kddf.com